Manufacturer record
Biocenna Healthcare Pvt.Ltd.Kh.No.218: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Biocenna Healthcare Pvt.Ltd.Kh.No.218 (Uttarakhand) were declared Not of Standard Quality in October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BCT-24-1906, Rabeprazole Sodium & Domperidone Tablets (Asterab-D) (exp Feb 2027). SDTL,Andhra Pradesh, Vijayawada (state lab) found it not of standard quality: Assay for Rabeprazole Sodium. Listed in the October 2025 alert.
Records by type
2 records linked to Biocenna Healthcare Pvt.Ltd.Kh.No.218 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium & Domperidone Tablets (Asterab-D) | Batch BCT-24-1906Mfg Mar 2025 · Exp Feb 2027 | Assay for Rabeprazole SodiumAssay | SDTL,Andhra Pradesh, VijayawadaState lab | Oct 2025 |
| Pantoprazole Gastro-Resistant Tablets IP (Astepan-40) | Batch BCT25-0153Mfg Apr 2025 · Exp Mar 2027 | Dissolution for PantoprazoleDissolution | SDTL,Andhra Pradesh, VijayawadaState lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.